Arrevus Competitors and Similar CompaniesClear all

Arrevus's competitors and similar companies include BIoEclipse Therapeutics and NKGen Biotech.
Arrevus
Arrevus
Arrevus is a biotechnology company providing therapies for orphan diseases.
BIoEclipse Therapeutics
BIoEclipse Therapeutics
BIoEclipse Therapeutics is a biopharmaceutical company developing curative immuno-oncology therapeutics.
NKGen Biotech
NKGen Biotech
NKGen Biotech (formerly known as NKMax America) is a biotechnology company that develops cell therapies for neurodegenerative and oncological diseases based on activated NK cells.
Founding Date
Founding Date
2017
Founding Date
N/A
Founding Date
2017
Type
Type
Subsidiary
Type
Private
Type
Public
Tags
Locations
Locations
HQ
Locations
South San Francisco, US HQ
Mountain View, US
Locations
Santa Ana, US HQ
Employees
Employees
3
Employees
614% decrease
Employees
7316% increase

Funding

Total funding raised
Total funding raised
$ 1m
Total funding raised
$ 7.7m
Total funding raised
$ 11m
For sources of this data, please see the company profile

View Company Profiles

BIoEclipse Therapeutics
HQ
South San Francisco, US
Employees
6↓ 14% decrease

BIoEclipse Therapeutics is a biopharmaceutical company developing curative immuno-oncology therapeutics.

View company
NKGen Biotech
HQ
Santa Ana, US
Employees
73↑ 16% increase

NKGen Biotech (formerly known as NKMax America) is a biotechnology company that develops cell therapies for neurodegenerative and oncological diseases based on activated NK cells.

View company